Skip to main content
. 2018 Apr;24(4):673–682. doi: 10.3201/eid2404.171480

Table 1. Geographic distribution of culture-confirmed invasive meningococcal disease isolates that have undergone whole- genome sequencing, United Kingdom, 2010–2016*.

Year
No. isolates by region†
No. laboratory-confirmed cases (% isolates)
Serogroup, no. isolates‡
1 2 3 4 Total PHE PHS A B C E NG W W/Y X Y Z
2010−11 464 37 36 13 550 1,009 (46.0) 76 (47.4) 1 423 13 1 5 27 2 1 76 1
2011−12 370 28 30 11 439 730 (50.7) 56 (53.6) 0 311 18 1 4 32 1 0 72 0
2012−13 415 29 34 13 491 769 (54.0) 66 (51.5) 0 325 29 0 7 51 1 0 78 0
2013−14 367 27 30 12 436 636 (57.7) 60 (50.0) 0 240 24 0 1 92 2 0 77 0
2014−15 483 19 55 15 572 724 (66.7) 65 (84.6) 0 283 23 0 5 172 2 0 87 0
2015−16
488
23
62
12
585

805 (60.6)
99 (62.6)

0
238
34
2
8
197
2
0
104
0
Total
2,587
163
247
76
3,073

4,673 (55.4)
442 (55.9)

1
1,820
141
4
30
571
10
1
494
1
*Laboratory-confirmed cases included culture-confirmed and PCR-confirmed cases. Data included in this study represented 55.4% of all laboratory-confirmed cases in England and 55.9% of those in Scotland. NG, nongroupable; PHE, Public Health England; PHS, Public Health Scotland.
†1, England; 2, Wales; 3, Scotland; 4, Northern Ireland.
‡W/Y serogroups were combined because of inconclusive serogrouping results.